Document Detail


Economic evaluation in clinical nephrology: part 2. Applying economic evaluations in clinical nephrology.
MedLine Citation:
PMID:  20649872     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our previous article described the principles of conducting an economic evaluation for evidence-based medical decision making. This article provides some tips for reading, critically appraising and applying the findings of an economic evaluation in clinical practice.
Authors:
Germaine Wong; Kirsten Howard; Jonathan C Craig
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nephrology (Carlton, Vic.)     Volume:  15     ISSN:  1440-1797     ISO Abbreviation:  Nephrology (Carlton)     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-23     Completed Date:  2010-11-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9615568     Medline TA:  Nephrology (Carlton)     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  533-9     Citation Subset:  IM    
Affiliation:
Centre for Kidney Research, The Children's Hospital at Westmead, New South Wales, Australia. germainw@chw.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / economics*,  therapeutic use*
Cost-Benefit Analysis
Drug Costs
Evidence-Based Medicine
Health Care Costs*
Health Services Research / economics*
Humans
Kidney Neoplasms / drug therapy*,  economics*
Models, Economic
Nephrology / economics*
Patient Selection*
Risk Assessment
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
Next Document:  What nephrologists need to know about diagnostic test accuracy articles.